*Refresh the page if the below document does not appear.
India’s drug authority has written a letter to WHO declaring that the samples of Maiden Pharma’s cough syrup allegedly causing the death of Gambian children were not found to be contaminated with diethylene glycol (DEG) and ethylene glycol (EG) upon testing by a technical committee of the Indian govt.
Bharat Serums and Vaccine Limited stated that they have entered into a definitive agreement to acquire Firstline Pharmaceuticals and Genomicks, to increase its presence in the women’s health and reproductive sector in Malaysia.
As reported by executives in an investor presentation, upcoming year Lilly has planned to submit regulatory applications for five products plus begin with six phase 3 trials and present data from six other phase 3 trials. All this will help the company earn more than $30 billion in sales next year.
One of the most profitable drugmaking company of the world is exiting pharmaceutical industry’s two major lobbying organizations the upcoming year, immediately after Washington pledges to cut down on increased drug costs.
Thea Pharma, Inc. has announced the approval of its NDA (New Drug Application) by the USFDA for its drug IYUZEH™ (latanoprost ophthalmic solution) 0.005% for indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
According to reports, Lilly is going to sell its API (Active Pharmaceutical Ingredient) for insulin at a significantly low price to Eva Pharma and will also provide a pro-bono technology transfer to help EVA Pharma to formulate, fill and finish insulin vials and cartridges.
The Biotech company,
declared that the first patient was dosed on
thursday for its Phase Ib drug interaction
study that aims to assess the interaction
between selective serotonin reuptake
inhibitors (SSRIs) and the Company’s lead N,
N-dimethyltryptamine (DMT) candidate.
If you don’t already have an account click the button below to create your account.Create New Account
Please update your profile to keep using the website